Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Psychiatry. 1982 Aug;139(8):1057-8.

Controlled trial of zimelidine, a 5-HT reuptake inhibitor, for treatment of depression.

Abstract

The authors conducted a double-blind, placebo-controlled clinical trial of the selective 5-HT reuptake inhibitor zimelidine in the treatment of major depressive illness. Zimelidine had the same antidepressant efficacy as amitriptyline but significantly fewer side effects, especially anticholinergic effects.

PMID:
6211994
DOI:
10.1176/ajp.139.8.1057
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center